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Abstract
Object We sought to measure brain metabolite levels in
healthy older people.
Materials and methods Spectroscopic imaging at the
level of the basal ganglia was applied in 40 participants
aged 73–74 years. Levels of the metabolites N-acetyl
aspartate (NAA), choline, and creatine were determined in
‘‘institutional units’’ (IU) corrected for T1 and T2 relaxa-
tion effects. Structural imaging enabled determination of
grey matter (GM), white matter (WM), and cerebrospinal
fluid content. ANOVA analysis was carried out for voxels
satisfying quality criteria.
Results Creatine levels were greater in GM than WM (57
vs. 44 IU, p \ 0.001), whereas choline and NAA levels
were greater in WM than GM [13 vs. 10 IU (p \ 0.001)
and 76 versus 70 IU (p = 0.03), respectively]. The ratio of
NAA/cre was greater in WM than GM (2.1 vs. 1.4,
p = 0.001) as was that of cho/cre (0.32 vs. 0.16,
p \ 0.001). A low voxel yield was due to brain atrophy and
the difficulties of shimming over an extended region of
brain.
Conclusion This study addresses the current lack of
information on brain metabolite levels in older adults. The
normal features of ageing result in a substantial loss of
reliable voxels and should be taken into account when
planning studies. Improvements in shimming are also
required before the methods can be applied more widely.
Keywords MR spectroscopy  Brain metabolites  Basal
ganglia  Ageing  Older adults  Healthy volunteers
Abbreviations
BGND Background (non-brain tissue and air)
CHESS Chemical shift selective
CSF Cerebrospinal fluid
GM Grey matter
LBC Lothian Birth Cohort
NAA N-acetyl aspartate
PRESS Point-resolved spectroscopy
WM White matter
Introduction
The study of normal brain ageing, neurodegenerative
conditions, and age-related cognitive decline is of
increasing interest as populations age. Magnetic resonance
imaging is proving to be a powerful tool for the evaluation
of structural and functional changes [1, 2]. Additionally,
magnetic resonance spectroscopy (MRS) can provide
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information on brain metabolites such as N-acetyl aspartate
(NAA), choline, creatine, and glutamate. Since metabolites
are related to cellular function, it is understandable that
brain metabolites have been studied for their associations
with cognitive function.
Although brain metabolite levels have been measured in
modest groups of young healthy subjects, there is relatively
little literature concerning older adults. As early as 1993,
Christiansen et al. [3] measured metabolite levels and
relaxation times in healthy young adults (n = 8; age 20–30)
compared with healthy elderly adults (n = 8; age 60–80).
They found a 15 % decline in occipital NAA in the older
group compared with the younger group. In a recent meta-
analysis of the available literature, Haga et al. [4] reported
reduced NAA and raised choline and creatine in healthy
older subjects ([60 years) relative to healthy younger sub-
jects (\60 years). Previously, we used a single-voxel MRS
technique and found an association between raised creatine
and a decline in cognitive ability [5]. Kantarci et al. [6]
reported a decreased NAA/creatine ratio in people with mild
cognitive impairment and Alzheimer’s disease relative to
cognitively normal, age-matched controls.
Magnetic resonance spectroscopic imaging (MRSI)
enables measurement of multiple voxels in a slice across
the brain and thereby opens up the possibility of producing
maps of metabolite distribution.
The objective of the current study was to establish brain
metabolite levels in healthy older adults within a narrow
age range. We employed strict criteria to discard spectro-
scopic voxels that failed various quality tests. We looked
for associations between metabolite levels, brain atrophy,
and cognitive scores.
Materials and methods
Participants
Forty participants (25 female) were recruited from healthy,
community-living people comprising the Lothian Birth
Cohort 1936 (LBC 1936 [7, 8]). All participants were aged
73 or 74 at the time of MRI scanning and formed a sub
group of approximately 650 volunteers who were part of a
longitudinal study on cognitive ageing [7] and for whom
recent detailed structural imaging [9] and cognitive scores
were available. The latter included general fluid intelli-
gence [10] and general memory [11]. An experienced
observer determined brain atrophy, iron, and white matter
(WM) lesion scores [12] from the structural images. Par-
ticipants with the lowest ratings were then selected for the
present spectroscopic study . The study was approved by
the local research ethics committee and all participants
gave informed written consent.
In order to avoid any possible confounding effects from
diurnal variation, all scans were performed at the same
time of day (between 11 a.m. and 1 p.m.).
Imaging
All imaging was performed on a 1.5T clinical research
scanner (HDxt, GE Healthcare, UK). The imaging protocol
for this spectroscopy study used a standard quadrature head
coil and included localiser, coronal T1-weighted (T1w: 3D-
IR-PREP-FAST-GRE), and axial T2-weighted (T2w: FSE)
scans in addition to an MRSI scan for brain metabolite
measurements. Key acquisition parameters for the T1w
scans were 3D inversion recovery-prepared, TI/TR/
TE = 500/10/4 ms, flip angle 8, matrix 192 9 192, FOV
256 mm slices of 1.3 mm thickness (156 slices total).
Parameters for the T2w scans were TR/TE = 4,000/
102 ms, matrix 256 9 256, FOV 240 mm, slices of 5 mm
thickness (28 slices total), and 2 signal averages.
The T2w images were used to plan a 10 mm thick axial
MRSI slice at a level that included the basal ganglia.
PRESS excitation was used with a volume of interest
(VOI) selected to cover the brain laterally and extend
forward from the posterior edge of the brain, avoiding the
frontal sinuses and orbits (Fig. 1). 24 9 24 phase-encoding
steps were applied over a field of view of 240 mm. Rep-
etition and echo times were 1,000 and 145 ms, respec-
tively. For each phase encode, 512 complex data points
were acquired with a sampling interval of 1 ms. Manu-
facturer-provided (first order) automatic shimming was
employed to reduce the B0 magnetic field inhomogeneity
prior to the MRSI acquisitions. Water suppression used the
default CHESS technique with three selective RF pulses.
Outer volume suppression employed pre-saturation slabs
parallel to the faces of the VOI and an additional four slabs
positioned around the edges of the brain to suppress lipid
artifacts from the scalp (Fig. 1). The total examination time
was approximately 30 min.
Image analysis
MRSI data were processed offline as described previously
[13]. Briefly, a two-dimensional spatial Fourier Transform
with cosine-weighted apodisation was applied to the raw
spectroscopic data, followed by zero-order phase and
eddy-current correction on a voxel-by-voxel basis using
the residual water signals, bringing water to a fixed
nominal chemical shift of 4.70 ppm [14]. The residual
water component was removed from each signal using the
Hankel Lanczos singular value decomposition technique
and the resulting signals quantified using the AMARES
algorithm within the MRUI package (www.mrui.uab.es).
A model consisting of three in-phase Gaussian
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components (corresponding to the major metabolite peaks
of choline, creatine, and NAA) and two inverted compo-
nents (corresponding to lactate) was used. Spectra were
automatically discarded if fitted line widths were\1 Hz or
[10 Hz; if the metabolite peaks were more than 0.1 ppm
offset from their nominal values; or if the voxels lay on
the edges of the PRESS excitation region. All spectra
were also inspected visually and discarded if judged to be
of poor quality, for example having a badly elevated
baseline or containing spurious peaks. Spectral peak areas
were corrected for relaxation effects using literature val-
ues for T1 and T2 in basal ganglia in elderly subjects [3]
and normalised according to the number of contributing
protons. The resulting institutional units are directly
related to molecular concentrations and enable compari-
son between studies.
Tissue segmentation maps for grey matter (GM), WM,
cerebrospinal fluid (CSF), and ‘‘background’’ (BGND)
were computed from the T1-weighted images using the
FSL-FAST algorithm (http://www.fmrib.ox.ac.uk). Previ-
ously available T2* (gradient-echo) images [9] were first
registered with the T1w and T2w images and used to create
brain masks. Air and non-brain tissue outside the mask was
classed as BGND. Tissue segmentation maps were then
generated and overlaid on the MRSI grid. For each spec-
troscopic voxel, the percentage of GM, WM, CSF, and
BGND content was calculated based on three contiguous
slices to match the extent of the MRSI acquisition. Spec-
troscopy voxels containing more than 20 % CSF or 5 %
BGND were rejected.
ANOVA (Matlab) and linear mixed effects (PASW
Statistics) analyses were carried out on metabolite levels,
with (%WM–%GM) as a variable and ‘‘subject’’ as a
random factor. Metabolite ratios were also analysed in the
same way. Subject-by-subject associations between
metabolite levels and structural and cognitive scores were
explored.
Results
Imaging and automatic brain segmentation succeeded in all
40 participants. Three participants who had fewer than five
spectroscopic voxels valid for NAA, choline, or creatine
were excluded from the subject-by-subject analysis.
Metabolite levels
Of the combined total of 6,476 voxels contained within the
MRSI PRESS excitation regions (Fig. 1), 1,432 survived
the spectral tests for NAA, and only 703 survived when
including choline and creatine. These 703 voxels were
included in the full ANOVA analyses reported in Table 1.
Figures 2 and 3 display the reasons for this attrition. There
Fig. 1 Sagittal and axial
localiser scan showing
placement of PRESS–MRSI
slab and additional saturation
bands (hatched) to minimise
lipid contamination
Table 1 Metabolite levels [in institutional units (IU): see text] and
metabolite ratios from ANOVA analysis of spectroscopic voxels in 40
subjects
WM GM p (GM vs WM)
Metabolites (IU)
NAA 76 70 0.03
Choline 13 10 \0.001
Creatine 45 57 \0.001
Metabolite ratios
NAA/Cho 8.2 9.8 0.06
NAA/Cre 2.1 1.4 \0.001
Cho/Cre 0.32 0.16 \0.001
Spectral peak area ratios
NAA/Cho 2.4 2.8 0.06
NAA/Cre 2.4 1.6 \0.001
Cho/Cre 1.3 0.7 \0.001
Ratios of spectral peak areas are also given for comparison with other
studies. Only voxels passing all spectral quality tests (see Figs. 2, 3
and text) are included
WM white matter, GM grey matter
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was a significant negative correlation between the per-
centage of valid voxels and the mean NAA line width (of
retained voxels) for each subject (r = -0.44, p = 0.005).
The main metabolite findings are that creatine levels were
significantly higher in GM than WM, whereas choline and
NAA levels were significantly higher in WM than GM.
Choline and creatine levels were highly correlated
(r = 0.55, p \ 0.001), whilst creatine and NAA showed a
weak negative correlation (r = -0.32, p = 0.05). NAA/
cre and cho/cre metabolite ratios were significantly greater
in WM than GM. The NAA/cho ratio was greater in GM
than WM, although this difference did not quite reach
significance (p = 0.06).
Relation to structural and cognitive scores
There was a trend for choline levels to be associated with
WM lesion scores (r = 0.24, p = 0.1). There were no
Fig. 2 MRSI grid superimposed on corresponding T2-weighted
image. The PRESS excitation box is outlined in red. Below is shown
the grid of spectra contained completely within the PRESS box,
colour coded according to: pale grey, ‘background’ (BGND), where
brain comprises \95 % of the voxel volume; grey, CSF more than
20 %; red, fitting of NAA peak failed; blue, failed visual quality test;
green, failed choline and/or creatine fitting but valid for NAA; black,
passed all tests. Tests were applied in the order described. For further
details, refer to text. The spectral range displayed is from 4 to 1 ppm
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associations between metabolites and either atrophy or iron
deposition scores. Creatine levels were correlated with
fluid intelligence (r = 0.33, p = 0.05), and NAA showed a
trend towards association with memory scores (r = 0.27,
p = 0.1).
Discussion
In this study we used MRSI to measure brain metabolite
levels in healthy elderly subjects. We looked for evidence
of tissue type differences and for associations with struc-
tural and cognitive scores. The narrow age range of the
Lothian Birth Cohort 1936 removes age as a potential
confounding factor, although it does preclude looking for
age-related effects in a single study such as this.
Our finding of higher creatine levels in GM than WM is
in agreement with previous literature reports, although the
magnitude of the difference varies greatly, being 27 % in
the present study, 11 % in Schuff et al. [15], 30 % in
Hetherington et al. [16], 40 % in Tal et al. [17], and as
much as 70 % in McLean et al. [18]. Our finding of lower
NAA levels in GM than in WM (70 vs. 76 IU) is consistent
with some previous reports [15, 16] but different from
others. For example, Tal et al. [17] averaged metabolite
values over a large centrally placed volume of brain and
found that NAA was 11 % higher in GM than WM. We
found choline levels lower in GM than WM, consistent
with previous reports [16, 18], although others have
reported no significant difference [15, 17]. Christiansen
et al. [3] found no difference in metabolite levels between
basal ganglia and the occipital, temporal, and frontal
regions in healthy elderly subjects. However, they used
large (8 mL) volumes of interest containing unspecified
proportions of GM and WM. Our results for metabolite
ratios are consistent with our findings for individual
metabolite levels. The reasons for the discrepancies in
metabolite findings between various studies are unclear but
will include exact details of the positioning, acquisition
method and quantification, and possible (unknown) dif-
ferences in metabolite T1 and T2 values between GM and
WM.
We used literature values for T1 and T2 correction and
also normalised the results by the number of protons con-
tributing to the spectral peaks (3 for NAA and creatine, 9
for choline). The final results in institutional units are
therefore closely related to molecular concentrations. Other
researchers, including [3] for example, have reported ratios
of spectral peak areas under experimental conditions, and
we have included these ratios in Table 1 to enable com-
parisons with other studies. We did not explore regional
variations because of the relatively low number of valid
voxels in particular regions, especially the frontal and
cortical regions. The chemical shift displacement between
choline and NAA amounted to approximately 0.5 mm
through-plane (i.e. 5 % of the slab thickness), 4 mm
anterior-posterior, and 6 mm left–right. Since we excluded
voxels around the edge of the excitation volume, these
displacements will have had minimal effect.
In this study we found a positive correlation between
creatine and fluid intelligence score, whereas previously [5]
we found a negative correlation between parietal cortex
creatine and memory scores but no association with other
cognitive measures. However, the two studies investigated
different brain regions.
As in recent work by Bainbridge et al. [19], we
employed strict criteria to discard spectroscopic voxels that
failed various quality tests. Although rather conservative,
such criteria can be applied with minimal human inter-
vention, will become important for future clinical studies,
and will be essential when large data sets from whole-brain
spectroscopy [20] become routinely available. The large
loss of voxels (Fig. 3) was caused by a high proportion of
CSF and failures of spectral quantification. In older people
with brain atrophy, it is inevitable that voxels will be lost
due to CSF and enlarged ventricles. Failures of quantifi-
cation were due in part to the problems of shimming over
Fig. 3 Exclusion of spectroscopic voxels for the cohort. 40 subjects
had a potential 6,476 voxels, of which 1,432 were valid for NAA after
spectral quality tests had been applied. Of these, 703 voxels were also
valid for choline and creatine measurement. Reasons for exclusion
were: background more than 5 % of voxel volume (BGND); CSF
more than 20 % (CSF); fitting of NAA peak failed (NAA); failed
visual quality test (Vis); failed choline and/or creatine fitting
(ChoCre), but valid for NAA. Tests were applied in the order
described, and the number of additional voxels failing each test is
given in the figure
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an extended region of the brain, which is especially diffi-
cult at the level of the basal ganglia. In some subjects, an
unavoidable tilt of the head relative to the scanner led to
portions of the frontal sinuses, ethmoid sinus, or eyes being
included in the MRSI plane. This is a particular problem in
older people, as they are less able to tilt their heads into the
optimum posture. Only first-order (linear) shimming was
available on the scanner used. In other studies (data not
shown) we have found greater success rates with MRSI
slices at the level of the corpus callosum. The use of
modern scanners with higher-order shims is likely to help,
as are higher field strengths and more sensitive multi-
channel coils enabling higher SNR and hence smaller
voxels with improved line widths. However, some brain
areas, for example the frontal and temporal regions, will
remain challenging in this regard.
A limitation of this study is that time did not permit the
collection of non-suppressed spectroscopic data for water
referencing purposes. Instead we used the residual water
signal for ‘‘self-referencing’’ [14]. Ideally, a rapid inter-
leaved (suppressed/reference) technique would be used, as
demonstrated by the echo-planar acquisition scheme of
Ebel and Maudsley [20].
Conclusions
The measurement of brain metabolites is potentially useful
in studies of healthy ageing and acute and neurodegener-
ative diseases. There is currently a lack of information on
metabolite levels in older adults. The current study of a
moderately sized cohort with a tight age range adds to the
available literature. However, technical challenges such as
shimming across the whole brain and water referencing
need to be resolved before the technique can be more
widely applied in large trials. Future directions include
rapid, three-dimensional, whole-brain coverage and longi-
tudinal studies.
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